Siliq (Valeant Pharmaceuticals North America LLC)
Welcome to the PulseAid listing for the Siliq drug offered from Valeant Pharmaceuticals North America LLC. This Interleukin-17 Receptor A Antagonist [EPC],Interleukin 17 Receptor A Antagonists [MoA],Antibodies, Monoclonal [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America LLC |
NON-PROPRIETARY NAME: | Brodalumab |
SUBSTANCE NAME: | BRODALUMAB |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Interleukin-17 Receptor A Antagonist [EPC],Interleukin 17 Receptor A Antagonists [MoA],Antibodies, Monoclonal [Chemical/Ingredient] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2017-02-15 |
END MARKETING DATE: | 0000-00-00 |
Siliq HUMAN PRESCRIPTION DRUG Details:
Item Description | Siliq from Valeant Pharmaceuticals North America LLC |
LABELER NAME: | Valeant Pharmaceuticals North America LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 210(mg/1) |
START MARKETING DATE: | 2017-02-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0187-0004_f5fb3c37-72ae-4dd7-bdf5-409351980ee0 |
PRODUCT NDC: | 0187-0004 |
APPLICATION NUMBER: | BLA761032 |
Other BRODALUMAB Pharmaceutical Manufacturers / Labelers: